SmartHarvest Portfolios LLC purchased a new position in Procter & Gamble Company (The) (NYSE:PG - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 7,225 shares of the company's stock, valued at approximately $1,035,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Trilogy Capital Inc. lifted its holdings in shares of Procter & Gamble by 1.1% in the 4th quarter. Trilogy Capital Inc. now owns 6,289 shares of the company's stock worth $901,000 after acquiring an additional 67 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its holdings in shares of Procter & Gamble by 1.8% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company's stock worth $549,000 after acquiring an additional 67 shares during the last quarter. Lorne Steinberg Wealth Management Inc. lifted its holdings in shares of Procter & Gamble by 2.7% in the 4th quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company's stock worth $376,000 after acquiring an additional 68 shares during the last quarter. Grant Street Asset Management Inc. lifted its holdings in shares of Procter & Gamble by 2.7% in the 4th quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company's stock worth $376,000 after acquiring an additional 69 shares during the last quarter. Finally, Beech Hill Advisors Inc. lifted its holdings in shares of Procter & Gamble by 0.5% in the 4th quarter. Beech Hill Advisors Inc. now owns 14,238 shares of the company's stock worth $2,040,000 after acquiring an additional 70 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Price Performance
PG stock opened at $148.50 on Friday. The firm's 50-day moving average price is $144.53 and its two-hundred day moving average price is $147.69. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25. The stock has a market capitalization of $345.80 billion, a price-to-earnings ratio of 21.71, a PEG ratio of 6.48 and a beta of 0.39. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm had revenue of $21.24 billion for the quarter, compared to analysts' expectations of $21.52 billion. During the same quarter in the previous year, the company earned $1.54 earnings per share. The company's revenue for the quarter was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a $1.0885 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date was Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 2.9%. Procter & Gamble's dividend payout ratio (DPR) is currently 63.60%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Procter & Gamble from $165.00 to $162.00 and set an "overweight" rating for the company in a report on Friday, April 17th. BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating for the company in a report on Thursday, April 23rd. Weiss Ratings reiterated a "hold (c)" rating on shares of Procter & Gamble in a report on Friday, March 27th. Piper Sandler boosted their price objective on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Friday, April 24th. Finally, Morgan Stanley decreased their price objective on shares of Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 22nd. Eleven research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $160.78.
Check Out Our Latest Stock Analysis on PG
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Commentary from investors and media continues to describe PG as a durable, dividend-oriented consumer staples name with steady cash flow, reinforcing the stock’s appeal as a defensive holding. Is The Procter & Gamble Company (PG) A Good Stock To Buy Now?
- Positive Sentiment: Jim Cramer highlighted P&G as one of the kinds of stocks that can help investors “safely own the techs,” reinforcing its role as a stable portfolio anchor during market volatility. Jim Cramer Says “The P&Gs and the J&Js in Your Portfolio Allow You to Safely Own the Techs”
- Positive Sentiment: P&G and OLAY announced virtual companion technology for skincare simulations, showing continued innovation in higher-engagement beauty and personal care products. Haut.AI Collaborates with OLAY on Virtual Companion Technology to Power Clinically Modeled Skincare Simulations
- Positive Sentiment: Brokerage coverage cited in a recent note showed PG still carrying an average “Moderate Buy” rating, which supports sentiment around the shares. Procter & Gamble Company The) (NYSE: PG Given Average Rating of "Moderate Buy" by Brokerages
- Neutral Sentiment: P&G and the American Academy of Family Physicians released an oral-health survey for Crest and Oral-B, mainly serving as a brand-marketing update rather than a clear earnings catalyst. New Survey from P&G and American Academy of Family Physicians Reveals 76% of Americans Say They Care About Their Oral Health, But When Polled, Only 3% of Americans Associate Oral Health with Whole Body Health
- Neutral Sentiment: PG also presented at the Evercore Consumer & Retail Conference, but the transcript headline alone does not indicate a major new financial surprise. The Procter and Gamble Company (PG) Presents at The 6th Annual Evercore Consumer and Retail Conference Transcript
- Negative Sentiment: Investors are also weighing restructuring news, including a leadership reshuffle and plans to cut more than 3,500 jobs globally, which could raise execution and transition concerns in the near term. Procter And Gamble Restructuring And Leadership Shift Create Valuation Watchpoints
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.